Utilizing Technology Solutions and Novel Medications in the Prevention, Diagnosis, and Management of Diabetes Mellitus

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Endocrinology & Metabolism".

Deadline for manuscript submissions: 20 October 2024 | Viewed by 111

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA
Interests: inpatient management of diabetes; hyperglycemia; hypoglycemia; continuous glucose monitoring (CGM) devices

E-Mail Website
Guest Editor
Division of Endocrinology, Diabetes & Metabolism, The Ohio State University College of Medicine, Columbus, OH, USA
Interests: diabetes complications; diabetes mellitus type 1; diabetes mellitus type 2; blood glucose self-monitoring

E-Mail Website
Guest Editor
Division of Endocrinology, Emory University, Atlanta, GA, USA
Interests: diabetic ketoacidosis; low blood sugar; pseudohypoparathyroidism; thyroid nodule; type 2 diabetes (t2d)

Special Issue Information

Dear Colleagues,

The prevalence of diabetes mellitus (DM) is rising globally, currently affecting more than 422 million people worldwide. The consequences of DM include macro-vascular and micro-vascular complications, which contribute to increased morbidity, mortality, and higher hospital costs. In this Special Issue of the Journal of Clinical Medicine, we aim to collate research papers that expand our knowledge on the use of technology and novel medications for the prevention, diagnosis, and management of DM. We welcome submissions of clinical intervention studies, observational real-world studies and metanalyses, as well as studies reporting patients’ outcomes.

We look forward to your submissions.

Dr. Elias K. Spanakis
Dr. Eileen R. Faulds
Dr. Alexandra L. Migdal
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • diabetes mellitus
  • continuous glucose monitoring
  • diabetes management
  • technology solutions

Published Papers

This special issue is now open for submission.
Back to TopTop